麻豆传媒

Phase III results, now published, should support approval

These eight specialties earn the least, with many averaging less than $300k per year

Trial finds conservative approach inferior to joint replacement

Study: It's not deprivation per se, but intervening factors that go with it

Looks like FDA blew the call on selective JAK1 inhibitor

Treatment patterns shift as new products come on board

Taking a page from HIV medicine

European registry analysis brings surprises along with the expected

But Japanese study suggests losses need to be substantial

Carefully structured run-walk program proves mettle in small trial

While imperfect relative to human experts, system might still be clinically useful

Only limited value when costs are considered, study suggests

MRI does occasionally reveal important findings missed on x-ray

Family, social, and financial stress compromises treatment, study suggests